ESC 365 - Risk of thromboembolic events without oral anticoagulation in consecutive patients at 90 days after surgical aortic valve replacement with a bioprosthesis

ESC Premium Access

Risk of thromboembolic events without oral anticoagulation in consecutive patients at 90 days after surgical aortic valve replacement with a bioprosthesis

Session: Anticoagulant strategies in cardio embolic disease

Topic: Aortic valve surgery

Speaker: Doctor T. Bourguignon (Tours, FR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Thierry Bourguignon

University Hospital of Tours, Tours (France)

0 follower

4 more presentations in this session

State of the art in unresolved issues in chronic anticoagulation.

Speaker: Professor G. Lip (Liverpool, GB)

Stroke and bleeding with NOAC and warfarin in patients with non-valvular atrial fibrillation in the Stockholm healthcare system

Speaker: Doctor T. Forslund (Stockholm, SE)

Predictors of thrombembolic events in left ventricular assist devices

Speaker: Miss E. Deniz (Hannover, DE)

Future direction for resarch in embolic stroke of unknown origin.

Speaker: Professor H. Diener (Essen, DE)

Access the full session

Anticoagulant strategies in cardio embolic disease

Speakers: Doctor T. Bourguignon, Professor G. Lip, Doctor T. Forslund, Miss E. Deniz, Professor H. Diener

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources